BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14569744)

  • 21. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 mutations in nonastrocytic human brain tumors.
    Ohgaki H; Eibl RH; Wiestler OD; Yasargil MG; Newcomb EW; Kleihues P
    Cancer Res; 1991 Nov; 51(22):6202-5. PubMed ID: 1933879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification.
    Imamura J; Bartram CR; Berthold F; Harms D; Nakamura H; Koeffler HP
    Cancer Res; 1993 Sep; 53(17):4053-8. PubMed ID: 8358734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The status of p53 gene in the primary retinoblastoma].
    Huang Q
    Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):248-51. PubMed ID: 11835813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
    Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low prevalence of p53, p16(INK4a) and Ha-ras tumour-specific mutations in low-graded actinic keratosis.
    Nindl I; Gottschling M; Krawtchenko N; Lehmann MD; Röwert-Huber J; Eberle J; Stockfleth E; Forschner T
    Br J Dermatol; 2007 May; 156 Suppl 3():34-9. PubMed ID: 17488404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
    Mueller W; Lass U; Wellmann S; Kunitz F; von Deimling A
    Acta Neuropathol; 2005 Mar; 109(3):314-20. PubMed ID: 15668788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of p53 dependent apoptosis in glia-derived tumors of the brain].
    Kaczmarczyk R; Słodziński H; Trojanowski T; Polz-Dacewicz M
    Neurol Neurochir Pol; 2001; 35 Suppl 5():30-3. PubMed ID: 11935677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [PCR-SSCP and sequencing analysis on mutations of anti-oncogene p53 in asbestos-related lung cancer].
    Fu D; Liu B; Miao Q; Wang H
    Wei Sheng Yan Jiu; 1997 Sep; 26(5):289-92. PubMed ID: 10325638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of p53 gene mutations in human leukemia by PCR-SSCP analysis and direct nucleotide sequencing.
    Wang R; Yu Z; Gu J; Li D; Wang M; Cao Y
    Chin Med J (Engl); 1998 Apr; 111(4):339-42. PubMed ID: 10374399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
    Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
    Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [High frequency mutation of p53 gene in human gastric cancer and precancerous lesions].
    Li Z; Lü Y
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):90-3. PubMed ID: 10920952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [p53 gene mutations in brain tumors].
    Koga H; Kumanishi T
    No To Shinkei; 1995 Sep; 47(9):845-55. PubMed ID: 7546933
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of p53 gene mutations: analysis by single-strand conformation polymorphism and Cleavase fragment length polymorphism.
    O'Connell CD; Atha DH; Oldenburg MC; Tian J; Siebert M; Handrow R; Grooms K; Heisler L; de Arruda M
    Electrophoresis; 1999 Jun; 20(6):1211-23. PubMed ID: 10380761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection and sequence analysis of the p53 gene mutation in epithelial ovarian cancer].
    Guan X; Lang J; Bian M
    Zhonghua Fu Chan Ke Za Zhi; 1998 Mar; 33(3):165-7. PubMed ID: 10682487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP53 mutations in malignant astrocytomas.
    Biernat W; Debiec-Rychter M; Kordek R; Liberski PP
    Pol J Pathol; 1997; 48(4):221-4. PubMed ID: 9529927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative assessment of the functional p53 status in glioma cells.
    Kim EL; Yoshizato K; Kluwe L; Meissner H; Warnecke G; Zapf S; Westphal M; Deppert W; Giese A
    Anticancer Res; 2005; 25(1A):213-24. PubMed ID: 15816541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India.
    Katiyar S; Hedau S; Jain N; Kar P; Khuroo MS; Mohanta J; Kumar S; Gopalkrishna V; Kumar N; Das BC
    Cancer Lett; 2005 Jan; 218(1):69-79. PubMed ID: 15639342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.